Compare MBIN & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MBIN | NEOG |
|---|---|---|
| Founded | 1990 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 2017 | 1989 |
| Metric | MBIN | NEOG |
|---|---|---|
| Price | $36.19 | $6.87 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $39.67 | $8.83 |
| AVG Volume (30 Days) | 148.8K | ★ 4.2M |
| Earning Date | 01-27-2026 | 01-09-2026 |
| Dividend Yield | ★ 1.11% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.34 | N/A |
| Revenue | $597,247,000.00 | ★ $886,886,000.00 |
| Revenue This Year | $5.57 | N/A |
| Revenue Next Year | $8.80 | $1.80 |
| P/E Ratio | $8.28 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $27.25 | $3.87 |
| 52 Week High | $43.82 | $13.41 |
| Indicator | MBIN | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 75.86 | 65.72 |
| Support Level | $33.88 | $5.82 |
| Resistance Level | $35.59 | $7.09 |
| Average True Range (ATR) | 0.88 | 0.28 |
| MACD | 0.36 | 0.12 |
| Stochastic Oscillator | 99.44 | 84.90 |
Merchants Bancorp is a United States based bank holding company. It operates multiple lines of business focusing on FHA (Federal Housing Administration) multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. The business segments of the company are: Multi-family Mortgage Banking which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing segment which funds agency-eligible residential loans as well as commercial loans to nondepository financial institutions; and the Banking segment, which generates maximum revenue, and provides various financial products and services to consumers and businesses.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.